Shares of Krsnaa Diagnostics Ltd jumped 4% in Tuesday's early trade after the company operationalised 100 more pathology collection centres in Mumbai on Monday.
In January, the company had bagged an order to provide services of lab investigation facilities under 'Hinduhridaysamrat Balasaheb Thakeray Chikitsa' for Brihanmumbai Municipal Corporation (BMC) dispensaries and hospitals in Mumbai.
The company in an exchange filing said that so far it has operationalised 300 pathology collection centres.
According to Rajesh Bhosale - Equity Technical and Derivative Analyst, Angel One, the stock started with a gap-up opening backed by volumes. However, it has slipped from morning highs. Overall, this stock has been an underperformer and bounce should be used to exit longs. ₹380 is support and ₹414 is resistance.
The stock hit an intraday high at ₹415.55 and intraday low at ₹395.40.
The stock has fallen 39.20% from its 52-week high of ₹655.0. The stock's weekly average delivery volume is 29.67%.
The stock price fell 27.3% and underperformed its sector by 26.6% in the past year.
According to a MintGenie poll, 2 analysts on an average recommend 'strong buy' rating for the stock.
